Nuclear factor E2-related factor 2 (NRF2) is a downstream target of the AKT signaling pathway and acts as a negative regulator of NF-κB during PD-associated neuroinflammation [54, 55]. This evidence concerns the gene AKT1 and Parkinson disease.